EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

Home-based respiratory-gated transcutaneous auricular vagus nerve stimulation for rheumatoid arthritis—a feasibility study

Ankit Parikh, Gwyn Lewis, Hamid GholamHosseini, Kristine Pek Ling Ng, Michal Kluger, Faisal Almesfer, Wee Leong Chang, David Rice

Clinical Rheumatology · 2026-05 · 45 (5) · 2627-2638

DOI: 10.1007/s10067-026-08041-x ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Clinical Rheumatology, online erschienen am 23.03.2026. Verfasst von Ankit Parikh und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Sciences, Auckland University of Technology, Auckland, 0627, New Zealand. mdd8317@autuni.ac.nz. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Vagus Nerve Stimulation, Transcutaneous Electric Nerve Stimulation. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Exsurgo Ltd, Auckland University of Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/objectives Rheumatoid arthritis is a chronic autoimmune disease that primarily affects the joints, causing pain, inflammation, and long-term joint damage. Transcutaneous auricular vagus nerve stimulation (taVNS) is a promising non-pharmacological intervention for managing pain and inflammation, particularly when delivered in the exhalation phase of respiration. However, until now, the lack of portable equipment has meant the respiratory phase effects have not been evaluated outside of the laboratory or in a home setting. The primary goal of this study was to determine the feasibility of a future clinical trial of home-based respiratory-gated taVNS in people with rheumatoid arthritis.

Methods

This was a single-arm, non-randomised feasibility trial involving 12 individuals with active rheumatoid arthritis. Participation involved 12 respiratory-gated taVNS sessions at home and three laboratory visits for outcome assessments (day 1, day 8, and day 15). Feasibility outcomes focused on recruitment rate, intervention adherence, acceptability questionnaires, and adverse events. In addition, outcome measures related to pain, psychological distress, and key inflammatory biomarkers were assessed.

Results

Feasibility outcomes demonstrated an acceptable recruitment rate, high adherence (90% session completion), excellent usability (9/10), and acceptability (average score 66%, general score 87%), with no severe treatment-emergent adverse events. While single-armed and not powered to determine efficacy, medium to large pre- to post-intervention reductions in pain interference, grip pain intensity, psychological distress, and tumour necrosis factor-alpha levels were observed, with minimal changes in other outcomes.

Conclusion

An adequately powered, randomised controlled trial of home-based respiratory-gated taVNS in people with rheumatoid arthritis is feasible and safe. Key Points • To the best of our knowledge, this study is the first to evaluate the feasibility of homebased respiratory-gated (RG) transcutaneous auricular vagus nerve stimulation (taVNS) for the treatment of rheumatoid arthritis (RA). • Feasibility outcomes demonstrated high adherence and excellent usability ratings with few treatment-emergent adverse events reported. • Home-based RG taVNS using the developed system is safe and feasible to evaluate in an adequately powered, controlled trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidVagus Nerve StimulationTranscutaneous Electric Nerve StimulationHumansFeasibility StudiesFemaleMiddle AgedMaleAgedTreatment OutcomeAdultHome Care Services

Stichwörter der Autor:innen

RARespiratory-gated stimulationRheumatoid arthritisTNF-αTaVNSTranscutaneous auricular vagus nerve stimulation

Autor:innen und Institutionen

  • School of Clinical Sciences, Auckland University of Technology, Auckland, 0627, New Zealand. mdd8317@autuni.ac.nz.
  • Exsurgo Ltd, 45I William Pickering Drive, Rosedale, Auckland, 0632, New Zealand. mdd8317@autuni.ac.nz.
  • Department of Physiotherapy, Auckland University of Technology, Auckland, 0627, New Zealand.
  • Department of Electrical and Electronic Engineering, Auckland University of Technology, Auckland, 1010, New Zealand.
  • Institute of Biomedical Technologies, Auckland University of Technology, Auckland, 1010, New Zealand.
  • Department of Rheumatology, Te Whatu Ora - Health New Zealand Waitematā, North Shore Hospital, Shakespeare Road, Takapuna, Auckland, 0622, New Zealand.

Förderung

  • Exsurgo Ltd
  • Auckland University of Technology

Zitieren

APA

Parikh, A., Lewis, G., GholamHosseini, H., Ng, K. P. L., Kluger, M., Almesfer, F., Chang, W. L., & Rice, D. (2026). Home-based respiratory-gated transcutaneous auricular vagus nerve stimulation for rheumatoid arthritis—a feasibility study. Clinical Rheumatology, 45(5), 2627-2638. https://doi.org/10.1007/s10067-026-08041-x

Vancouver

Parikh A, Lewis G, GholamHosseini H, Ng KPL, Kluger M, Almesfer F, et al. Home-based respiratory-gated transcutaneous auricular vagus nerve stimulation for rheumatoid arthritis—a feasibility study. Clinical Rheumatology. 2026;45(5):2627-2638. doi:10.1007/s10067-026-08041-x

BibTeX
@article{Parikh2026,
  author = {Parikh, Ankit and Lewis, Gwyn and GholamHosseini, Hamid and Ng, Kristine Pek Ling and Kluger, Michal and Almesfer, Faisal and Chang, Wee Leong and Rice, David},
  title = {Home-based respiratory-gated transcutaneous auricular vagus nerve stimulation for rheumatoid arthritis—a feasibility study},
  journal = {Clinical Rheumatology},
  year = {2026},
  volume = {45},
  number = {5},
  pages = {2627--2638},
  doi = {10.1007/s10067-026-08041-x}
}
Kostenlos starten →